Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
Recruiting · NCT05377307 · Registry updated 2026-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, histiocytosis, immune system disorder, immunoproliferative disorder, interdigitating dendritic cell sarcoma, large B-cell lymphoma, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, malignant histiocytosis, neoplasm | Recruiting | Not stated | 2026-10-09 | NCT05377307 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pell Bio-Med Technology Co., Ltd. | 2 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chi Mei Medical Center | Tainan | Taiwan | 9 |
| Kaohsiung Medical University Chung-Ho Memorial Hospital | Kaohsiung | Taiwan | 1 |
| National Taiwan University Hospital | Taipei | Taiwan | 1 |
| Taipei Medical University - Taipei Medical University Hospital | Taipei | Taiwan | 2 |
| Taipei Veterans General Hospital | Taipei | Taiwan | 2 |